Boothbay Fund Management’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$842K Sell
145,000
-15,311
-10% -$102K 0.01% 1211
2026
Q1
$1.16M Sell
160,311
-74,488
-32% -$970K 0.02% 872
2025
Q4
$3.99M Buy
234,799
+113,637
+94% +$1.15M 0.06% 357
2025
Q3
$887K Sell
121,162
-11,729
-9% -$94.9K 0.01% 881
2025
Q2
$864K Buy
132,891
+86,145
+184% +$569K 0.02% 738
2025
Q1
$378K Sell
46,746
-14,719
-24% -$161K 0.01% 968
2024
Q4
$760K Sell
61,465
-112,647
-65% -$1.5M 0.02% 723
2024
Q3
$1.43M Buy
174,112
+6,556
+4% +$39.2K 0.03% 638
2024
Q2
$836K Sell
167,556
-4,370
-3% -$24.9K 0.02% 778
2024
Q1
$1.06M Buy
+171,926
New +$861K 0.02% 739
2023
Q2
– Sell
-23,166
Closed -$100K – 2361
2023
Q1
$100K Buy
23,166
+7,066
+44% +$32.4K ﹤0.01% 1936
2022
Q4
$113K Buy
+16,100
New +$74.2K ﹤0.01% 1755
2022
Q3
– Sell
-27,932
Closed -$91K – 2642
2022
Q2
$91K Sell
27,932
-86,347
-76% -$166K ﹤0.01% 2000
2022
Q1
$229K Hold
114,279
– – 0.01% 1805
2021
Q4
$359K Hold
114,279
– – 0.01% 1178
2021
Q3
$560K Buy
+114,279
New +$693K 0.02% 1033
2020
Q3
– Sell
-16,000
Closed -$167K – 1245
2020
Q2
$167K Buy
+16,000
New +$151K 0.01% 822

Other funds holding WVE

Boothbay Fund Management's WVE Position: Q2 2026 in Review

Boothbay Fund Management reduced its Wave Life Sciences (WVE) stake by 9.6% in Q2 2026, selling an estimated $102K and leaving 145,000 shares worth $842K. The position accounts for 0.01% of the portfolio, ranked #1211.

Boothbay Fund Management first reported a position in WVE in Q2 2020 and has held it in 17 quarters since. The position peaked at $3.99M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Boothbay Fund Management held 145,000 shares of Wave Life Sciences worth $842K as of Q2 2026.
  • Boothbay Fund Management sold 15,311 Wave Life Sciences shares in Q2 2026, an estimated $102K.
  • Wave Life Sciences made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1211 holding.
  • Boothbay Fund Management first reported a position in Wave Life Sciences in Q2 2020 and has held it in 17 quarters since.
  • Boothbay Fund Management's Wave Life Sciences position peaked at $3.99M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.